Business Context and Reporting Period
This Form 8-K is filed by NorthView Acquisition Corp. (NVAC), a Delaware corporation, on June 5, 2025. The filing reports on events related to the proposed Business Combination with Profusa, Inc., originally announced in November 2022 and amended multiple times through April 2025. The filing details a Non-Redemption Agreement and the adjournment of a special stockholder meeting.
Key Financial Metrics and Transactions
- Non-Redemption Transaction: Investors (I-Bankers Securities, Inc. and Dawson James Securities, Inc.) purchased 100,000 shares of NVAC common stock at $12.51 per share from a hedge fund owning less than 5% of outstanding stock.
- Trust Account Threshold: The Non-Redemption Agreement is triggered if redemptions reduce the trust account balance below $1.25 million.
- Redemptions: Stockholders redeemed 52,784 shares of common stock in connection with the special meeting.
- Financial Statements: The filing does not provide revenue, profit, cash flow, margins, or debt figures for the reporting period.
Material Changes and Events
- Meeting Adjournment: The special meeting of stockholders to approve the Business Combination, originally scheduled for June 9, 2025, at 10:00 a.m. ET, was adjourned.
- Reconvened Meeting: The meeting is scheduled to reconvene on June 9, 2025, at 4:30 p.m. ET via live teleconference.
- Strategic Intent: The share purchases under the Non-Redemption Agreement aim to increase cash available at closing and potentially improve the likelihood of Nasdaq listing approval.
Guidance, Outlook, and Risks
- Management Commentary: Management states the Non-Redemption Agreement purchases are not expected to impact the likelihood of stockholder approval but may assist with Nasdaq listing requirements.
- Risks and Contingencies: The filing notes that the reduction in redemptions could alter the perception of the Business Combination's strength. The transaction is structured to comply with Rule 14e-5 under the Exchange Act.
- Outlook: No specific financial guidance or revenue outlook is provided in this filing.
Investor Verification Checklist
- Verify the final redemption count and trust account balance following the reconvened meeting on June 9, 2025.
- Confirm whether the Business Combination receives final stockholder approval at the reconvened meeting.
- Review the full text of the Non-Redemption Agreement (Exhibit 10.1) for specific terms regarding the waiver of redemption rights.
- Monitor Nasdaq's decision regarding the listing of the combined entity's securities post-closing.